InterGenetics provides employees with a modern and innovative work environment that empowers comprehensive scientific training and professional fulfillment. By utilizing modern methods and selection techniques, it attracts highly qualified executives, who, through ongoing training and progressive professional mindset, make significant contributions to the exceptional quality of the services offered.
Dr Voula Velissariou
Voula Velissariou is a Laboratory Clinical Geneticist and the Scientific and Managing Director of Intergenetics, a Medicover Company, Greece.
Her main expertise is in the field of diagnosis of human gene disorders and chromosomal abnormalities. She has a BSc in Biology from the National University of Athens and a PhD in Genetics from the University of Cambridge. She worked as a postdoctoral fellow in Cambridge in Cytogenetics and specialized in Clinical Cytogenetics after training at Churchill Hospital, Oxford. She has worked in Prenatal Diagnosis at the Department of Medical Genetics of the 1st Pediatric Clinic of University of Athens at St. Sofia Hospital and the Department of Genetics at Alexandra Hospital, Athens. In 1998 she became Head of the newly founded Department of Genetics and Molecular Biology at Mitera Hospital, Athens, where she was head until 2013 and member of the Scientific Board. From 2013 to 2015 she was Director of Cytogenetics at AlfaLab of Hygeia Group. From 2016-2022 she was the Scientific Director of Genetics and Molecular Biology at Bioiatriki Health Services, Greece and member of the Scientific Board.
She participated in the scientific group that developed VERACITY, one the most credible NIPT tests in the field. She is a founding and elected member of the Board of the Hellenic Association of Medical Genetics (SIGE)(2005-2007 and 2022-2024). In 2019 she participated in the SIGE committee appointed by the Ministry of Health for the requirements for acquiring the specialty in Laboratory Genetics. She is also elected representative of SIGE at the European Cytogeneticists Association. She was assessor of the Hellenic Accreditation System ESYD for Clinical Cytogenetics laboratories and the Cyprus Accreditation Body (CYS-CYSAB) for several years. She is a member of the scientific board and a Medical Genetics Consultant at Medicover Genetics, Cyprus. She is the author of several articles in her field, reviewer and co-author of several articles in genetic diagnostics and NIPT.
